
|Articles|July 23, 2021
The Mainstream Patient: July 23, 2021
Author(s)Morgan Petronelli
This week’s edition of The Mainstream Patient features stories about a new TikTok-inspired acne treatment, skin care ingredient absorption, injectable psoriasis treatments, plus more.
Advertisement
In this week’s edition, Allure dives into injectable psoriasis treatments, features a new TikTok trend using sea salt water to treat acne, and explains why there is a rise in Black people getting fillers and Botox. Also, Hello Giggles details what sun allergies are and reveals how skin care ingredients are really absorbed into the skin. Finally, Harper's Bazaar highlights hormone testing as the next big thing in skin care.
Advertisement
Related to this article

From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.

Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.

The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.

Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting CSU evidence.

Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.

Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Tildrakizumab for Active Psoriatic Arthritis
2
The Scariest Skin Care Trends Haunting Patients This Halloween
3
October Social Media Mythbusters: 3 Viral Beauty Claims, Debunked
4
Improving Early Identification and Escalation of HS
5


